Spain, Germany, France and Italy have become the latest European countries to temporarily halt the rollout of the Oxford-AstraZeneca COVID-19 vaccine over a small number of blood clot concerns.
Spain, Germany, France and Italy have become the latest European countries to temporarily halt the rollout of the Oxford-AstraZeneca COVID-19 vaccine over a small number of blood clot concerns, going against the advice of international medical agencies as a third wave of infections looms over the continent. Spain will stop using the vaccine for two weeks, the country’s Health Minister Carolina Darias announced in a nationally televised news conference Monday. It’s a „temporary and precautionary“ suspension, she said, „until the risks can be evaluated by the European Medicines Agency.“After initially standing by the safety of the vaccine, German health minister Jens Spahn said Monday that the country would pause inoculations as a precaution, following reports of a handful of cases of blood clots in people vaccinated with the AstraZeneca shot in Denmark and Norway. France and Italy also halted their rollouts of the vaccine Monday, pending review by the EU’s medicines regulator, the European Medicines Agency (EMA), although the body later reiterated its advice that countries stick to the rollout.“We have decided to suspend the use of AstraZeneca as a precautionary measure and are hoping to resume it quickly if the EMA’s advice allows it,“ French President Emmanuel Macron said at Monday news conference. The suspensions came hours after prosecutors in northern Italy ordered a batch of the vaccine to be seized, citing a man who fell ill and died after taking a shot. Italy’s medicines agency also suspended the use of the AstraZeneca vaccine „as a precaution and temporarily,“ prior to the EMA meeting, the Italian medicines agency AIFA announced Monday. Much of Europe has now halted the shot for the time being, following the fatality of one woman in Denmark that has yet to be linked to a vaccine. Another death was also reported in Norway on Monday, along with a handful of non-fatal cases in both countries. The suspensions go against the advice of the World Health Organization, the EMA and the pharmaceutical giant itself, all of whom have said there is no evidence of a link with clotting and that rollouts should continue while the reports are investigated.“As of today, there is no evidence that the incidents are caused by the vaccine and it is important that vaccination campaigns continue so that we can save lives and stem severe disease from the virus,“ the WHO said in a statement to CNN. The organization added it was assessing the latest reports, but said any change in its recommendations would be „unlikely.“The EMA also reiterated that countries should continue their rollouts, adding that it would meet on Thursday to discuss the concerns but that the benefit of vaccinations outweigh any potential risks.
